Go Deep
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -21,164 | -2.8 | -7.45 | 0.01 | 1,531.36 |
| Oct 2026 | -21,409 | -2.9 | -7.72 | 0.01 | 1,583.72 |
| Oct 2026 | -21,784 | -2.9 | -8.15 | 0.01 | 1,671.31 |
| Oct 2026 | -21,878 | -3.1 | -8.26 | 0.01 | 1,688.77 |
| Oct 2026 | -21,862 | -3.1 | -8.24 | 0.01 | 1,686.78 |
| Oct 2026 | -22,469 | -3.3 | -8.93 | 0.01 | 1,828.06 |
| Oct 2026 | -22,653 | -3.4 | -9.13 | 0.01 | 1,866.11 |
| Oct 2026 | -23,073 | -3.6 | -9.61 | 0.01 | 1,959.55 |
Seaport Therapeutics, Inc. Quarterly Results
| Line Item | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -25,408,000.0 | -13,125,000.0 |
| EPS | -0.5 | -0.3 |
Seaport Therapeutics, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -74,881,000.0 | -46,879,000.0 |
| EPS | -1.9 | -1.2 |
Seaport Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 249,009,000.0 | 315,777,000.0 |
| Total Liabilities | 341,554,000.0 | 340,626,000.0 |
| Total Equity | -92,545,000.0 | -24,849,000.0 |
Owes vs Owns
Seaport Therapeutics, Inc. owed $1.51 for every $1 it owned in Mar 2026, up from $1.08 in Dec 2024.
| Period | Mar 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 1.51× | 1.37× | 1.08× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Seaport Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 86.7%Receivables 1.2%Fixed assets (tangible) 2.1%Long-term investments 7.1%Other assets 2.9%
How it's funded — Dec 2025
Long-term debt 1.0%Payables 0.6%Other liabilities 97.9%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 216.0 | 309.1 |
| Receivables | 3.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 5.2 | 5.2 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 17.7 | 0.0 |
| Other assets | 7.1 | 1.5 |
| Liabilities & equity | ||
| Short-term debt | 1.6 | 0.9 |
| Long-term debt | 3.4 | 4.1 |
| Payables | 2.0 | 4.7 |
| Other liabilities | 334.5 | 330.9 |
| Shareholders' equity | -92.5 | -24.8 |
| Net tangible assets | -92.5 | -24.8 |
Seaport Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -77,942,000.0 | -29,629,000.0 |
| Investing Activities | -184,245,000.0 | -113,000.0 |
| Financing Activities | -873,000.0 | 339,295,000.0 |